Comparison of Vaccine Strategies Using Recombinant env–gag–pol MVA with or without an Oligomeric Env Protein Boost in the SHIV Rhesus Macaque Model-Reference-Cited by-同舟云学术

Comparison of Vaccine Strategies Using Recombinant env–gag–pol MVA with or without an Oligomeric Env Protein Boost in the SHIV Rhesus Macaque Model

Published:2002-03 Issue:2 Volume:294 Page:270-281
ISSN:0042-6822
Container-title:Virology
language:en
Short-container-title:Virology

Author:

Earl Patricia L.,Wyatt Linda S.,Montefiori David C.,Bilska Miroslawa,Woodward Ruth,Markham Phillip D.,Malley James D.,Vogel Thorsten U.,Allen Todd M.,Watkins David I.,Miller Nancy,Moss Bernard

Publisher

Elsevier BV

Subject

Virology

Reference64 articles.

1. Characterization of the peptide binding motif of a rhesus MHC class I molecule (Mamu-A*01) that binds an immunodominant CTL epitope from SIV;Allen;J. Immunol.,1998

2. Induction of AIDS virus-specific CTL activity in fresh, unstimulated peripheral blood lymphocytes from rhesus macaques vaccinated with a DNA prime/modified vaccinia virus Ankara boost regimen;Allen;J. Immunol.,2000

3. Phenotypic analysis of antigen-specific T lymphocytes;Altman;Science,1996

4. Control of a mucosal challenge and prevention of AIDS in rhesus macaques by a multiprotein DNA/MVA vaccine;Amara;Science,2001

5. The complete genomic sequence of the modified vaccinia Ankara strain: Comparison with other orthopoxviruses;Antoine;Virology,1998

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic-Based Vaccine Vectors;Plotkin's Vaccines;2023

2. Rectal Acquisition of Simian Immunodeficiency Virus (SIV) SIVmac239 Infection despite Vaccine-Induced Immune Responses against the Entire SIV Proteome;Journal of Virology;2020-11-23

3. Vaccine Design Informed by Virus-Induced Immunity;Viral Immunology;2020-05-01

4. DNA Vaccine–Induced Long-Lasting Cytotoxic T Cells Targeting Conserved Elements of Human Immunodeficiency Virus Gag Are Boosted Upon DNA or Recombinant Modified Vaccinia Ankara Vaccination;Human Gene Therapy;2018-09

5. Development of Gene-Based Vectors for Immunization;Plotkin's Vaccines;2018